abstract |
Using specific administration protocols and dosage regimens, 3,3 ', 4,4'-tetrahydroxy-2,2'-bipyridine-N, N'-oxide compounds, in particular, 3,3', 4, Provided are pharmaceutical compositions suitable for use in therapeutic methods as well as methods of treating kidney cancer by administering 4'-tetrahydroxy-2,2'-bipyridine-N, N'-dioxide (orellanin). |